XML 41 R31.htm IDEA: XBRL DOCUMENT v3.24.0.1
Equity Incentive Plans (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Equity Incentive Plans    
Schedule of stock-based compensation expense

Stock-based compensation expense was allocated as follows (in thousands):

Three Months Ended

Nine Months Ended

September 30, 

September 30, 

    

2023

    

2022

2023

    

2022

    

Cost of goods sold

$

12

$

29

$

69

$

104

Research and development 

94

90

261

284

Selling and marketing

10

40

73

120

General and administrative 

 

323

 

377

 

1,015

 

1,461

Total

$

439

$

536

$

1,418

$

1,969

Year Ended

December 31, 

    

2022

    

2021

    

2020

Cost of goods sold

$

133

$

271

$

14

Research and development 

372

490

651

Selling and marketing

155

148

108

General and administrative 

 

1,833

 

2,429

 

2,045

Total

$

2,493

$

3,338

$

2,818

Schedule of assumptions used to compute employee stock-based compensation  

    

2022

    

2021

    

2020

 

Risk‑free interest rate

 

1.71% - 4.22

%  

.66% - 1.51

%  

.40% - 1.68

%

Expective volatility

 

107% ‑ 118

%  

105% ‑ 106

%  

65% ‑ 106

%

Expected dividend yield

 

0

%  

0

%  

0

%

Expected life (in years)

 

6.25

 

6.25

 

6.25

Summary of options outstanding, vested and exercisable  

    

    

    

Weighted

    

 

Weighted

 

Average

 

 

Average

 

Remaining

 

Exercise

 

Contractual

Aggregate

Options

Price

 

Life (Years)

Intrinsic Value

Options outstanding at December 31, 2020

 

212,946

 

125.29

 

6.3

 

  

Options granted

 

64,528

 

105.00

 

  

 

  

Options exercised

 

(3,159)

 

23.80

 

  

 

  

Options cancelled/forfeited

 

(15,170)

 

264.46

 

  

 

  

Options outstanding at December 31, 2021

 

259,145

 

113.33

 

6.1

 

  

Options granted

 

187,454

 

3.97

 

  

 

  

Options exercised

 

 

 

  

 

  

Options cancelled/forfeited

 

(48,781)

 

97.44

 

  

 

  

Options outstanding at December 31, 2022

 

397,818

 

63.75

 

7.7

$

6

Options exercisable at December 31, 2022

 

182,667

 

113.54

 

5.7

$

Vested and expected to vest at December 31, 2022

 

397,818

 

  

 

  

$

6

Schedule of restricted stock activity  

    

    

Weighted Average

    

Aggregate

Shares

 

Grant Date Fair Value

 

Intrinsic Value

Restricted stock units outstanding at December 31, 2020

 

3,988

 

 

$

458

Granted

 

7,433

 

67.27

Vested

(3,096)

112.73

Restricted stock units outstanding at December 31, 2021

 

8,325

 

$

163

Granted

4,690

1.05

Vested

 

(6,554)

 

76.30

Restricted stock units outstanding at December 31, 2022

 

6,461

 

$

2